Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Digital karyotyping technology: exploring the cancer genome.

Parrett TJ, Yan H.

Expert Rev Mol Diagn. 2005 Nov;5(6):917-25. Review.

PMID:
16255633
2.

Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.

Di C, Liao S, Adamson DC, Parrett TJ, Broderick DK, Shi Q, Lengauer C, Cummins JM, Velculescu VE, Fults DW, McLendon RE, Bigner DD, Yan H.

Cancer Res. 2005 Feb 1;65(3):919-24.

3.

Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas.

Broderick DK, Di C, Parrett TJ, Samuels YR, Cummins JM, McLendon RE, Fults DW, Velculescu VE, Bigner DD, Yan H.

Cancer Res. 2004 Aug 1;64(15):5048-50.

4.

Monoclonal antibody induced hearing loss.

Nair TS, Raphael Y, Dolan DF, Parrett TJ, Perlman LS, Brahmbhatt VR, Wang Y, Hou X, Ganjei G, Nuttall AL, et al.

Hear Res. 1995 Mar;83(1-2):101-13.

PMID:
7607976

Supplemental Content

Loading ...
Support Center